Featured Press Releases

RiDYMO® develops a cyclic peptide targeting the

RiDYMO® develops a cyclic peptide targeting the "undruggable" β-catenin in just two months

Abcentra LLC Commences Phase 2b

Abcentra LLC Commences Phase 2b 'FORTIFY' Trial with First Patient Dosed, Evaluating Orticumab for Cardiovascular Disease

  • 12 Aug 2025

Abcentra LLC, a clinical-stage biopharmaceutical company pioneering targeted therapies for...

Avanzanite forms a Pan-European partnership with Agios to introduce PYRUKYND® for rare blood disorders

Avanzanite forms a Pan-European partnership with Agios to introduce PYRUKYND® for rare blood disorders

Sanguine Expands Oncology Biospecimen Portfolio via Strategic Clinic Partnerships

Sanguine Expands Oncology Biospecimen Portfolio via Strategic Clinic Partnerships

LOTUS study data on DAYBUE® (trofinetide) for Rett Syndrome

LOTUS study data on DAYBUE® (trofinetide) for Rett Syndrome's long-term efficacy and tolerability is published in Developmental Medicine and Child Neurology

Optune Lua® from Novocure has received approval in Japan for treating unresectable advanced/recurrent Non-Small Cell Lung Cancer (NSCLC)

Optune Lua® from Novocure has received approval in Japan for treating unresectable advanced/recurrent Non-Small Cell Lung Cancer (NSCLC)

Eli Lilly’s Foundayo™: The Newest GLP-1 Innovation Offered by Ro

Eli Lilly’s Foundayo™: The Newest GLP-1 Innovation Offered by Ro

  • Ro
  • 09 Apr 2026
Approval and Launch of Nintedanib Capsules

Approval and Launch of Nintedanib Capsules

  • Dexcel Pharma USA
  • 09 Apr 2026
When Every Beat Matters, BD Helps Clinicians Gain Continuous, Noninvasive Blood Pressure Insight to Eliminate Blind Spots

When Every Beat Matters, BD Helps Clinicians Gain Continuous, Noninvasive Blood Pressure Insight to Eliminate Blind Spots

  • BD
  • 07 Apr 2026
Dr. Amit Singal Appointed as Chief Medical Officer by Curve Biosciences

Dr. Amit Singal Appointed as Chief Medical Officer by Curve Biosciences

  • Curve Biosciences
  • 07 Apr 2026
MEDIPEEL Gains Momentum in the K-Pharmacy Channel in Korea.

MEDIPEEL Gains Momentum in the K-Pharmacy Channel in Korea.

  • MEDIPEEL
  • 06 Apr 2026
Epia Neuro Launches Intent-Driven Neural Technology to Restore Function After Stroke and Address Cognitive Decline

Epia Neuro Launches Intent-Driven Neural Technology to Restore Function After Stroke and Address Cognitive Decline

  • Epia Neuro
  • 06 Apr 2026
Drug Discovery 2024
The Digital Pharma Advances Conference 2026

Most Popular
April   2026
M T W T F S S
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.